Description
Weight management support that fits into your routine — no injections, no mixing, no refrigeration required.
Our compounded semaglutide rapid dissolve tablet (RDT) delivers the same active GLP-1 receptor agonist as injectable formulations in a convenient sublingual format. Simply place the tablet under your tongue and let it dissolve — the thin oral mucosa membrane allows for direct absorption into the bloodstream, bypassing the digestive tract.
Formulated and dispensed by a licensed 503A compounding pharmacy, each tablet is customized to your prescribed dose and packaged for straightforward daily use.
How To Use
- Place one tablet under your tongue as directed by your prescribing provider.
- Allow the tablet to dissolve fully — typically within 60–90 seconds. Do not swallow or chew.
- Avoid eating or drinking for at least 15 minutes before and after administration.
- Use as prescribed. Doses are typically titrated over time under medical supervision.
What To Expect
Semaglutide works by mimicking the GLP-1 hormone, which plays a role in regulating appetite and blood sugar. Most patients on a consistent protocol report reduced hunger and improved satiety — effects that support sustainable caloric reduction over time. Results vary by individual, starting dose, and adherence to your provider’s guidance.
This is a prescription medication. A valid prescription from a licensed healthcare provider is required to complete your order. Our care team will verify your prescription before dispensing.
This product is a compounded medication and has not been evaluated or approved by the FDA for safety or efficacy. Compounded medications are not substitutes for FDA-approved drugs. This product is intended for use only under the supervision of a licensed healthcare provider. Results may vary. Not suitable for individuals who are pregnant, breastfeeding, or with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
There are no reviews yet.